论文部分内容阅读
血流导向装置治疗颅内动脉瘤后自发性脑实质内出血是非常严重的并发症,原因尚不清楚。美国学者Brinjikji等通过Pipeline栓塞装置的国际回顾性研究,分析了治疗患者的基线资料、颅内动脉瘤以及治疗特点与自发性脑实质内出血之间的关系。他们认为,研究对象的脑实质内出血与Pipeline栓塞装置治疗后颅内动脉瘤破裂无相关性。脑实质内出血发生率由患者的基线情况、合并症、动脉瘤特点以及治疗特点所决
The reason why the flow-guiding device is a very serious complication of spontaneous intraparenchymal hemorrhage after intracranial aneurysm treatment is not clear. American scholar Brinjikji and other international retrospective study of the Pipeline embolization device, the analysis of the treatment of patients with baseline data, intracranial aneurysms and treatment characteristics and the relationship between spontaneous intraparenchymal hemorrhage. In their opinion, there was no correlation between the brain intraparenchymal hemorrhage and the ruptured intracranial aneurysm following the Pipeline embolization device. The incidence of intraparenchymal hemorrhage was determined by the patient’s baseline condition, comorbidity, aneurysm characteristics, and treatment characteristics